Tampere University is starting a study on Post-Finasteride Syndrome. PFS and PSSD share the same symptom profile and potentially the same underlying mechanism of the disease.

​

Finasteride is used in younger men for the treatment of male-pattern baldness.

​

The objectives of the study include, among others:

• Understanding the genetic predisposition to the development of PFS

• Understanding why some individuals become affected while others do not

• Assisting clinicians in diagnosing PFS more quickly and accurately

• Understanding the fundamental pathomechanism and, hopefully, ultimately identifying a target for the development of precise medical treatment for PFS.